Beam Therapeutics Profile Banner
Beam Therapeutics Profile
Beam Therapeutics

@BeamTx

Followers
4,923
Following
203
Media
398
Statuses
518

Our vision is to provide life-long cures for patients suffering from serious diseases. #DaretoBeam #BeamTeam

Cambridge, MA
Joined December 2017
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@BeamTx
Beam Therapeutics
3 years
Today we announced an exclusive, four-year research collaboration with @pfizer focused on in vivo base editing programs. Together, we look forward to advancing potentially transformative therapies for patients living with genetic #rarediseases . Read more:
Tweet media one
1
11
95
@BeamTx
Beam Therapeutics
2 years
Today, Beam announced that the first patient has been enrolled in the company’s BEACON trial. BEACON is an open-label, single-arm, multicenter, Phase 1/2 clinical trial designed to evaluate the safety and efficacy of BEAM-101 in adult patients with severe sickle cell disease
1
13
94
@BeamTx
Beam Therapeutics
3 years
Today Beam announced that its Investigational New Drug (IND) application for BEAM-101 for the treatment of sickle cell disease was cleared by the U.S. Food and Drug Administration. Learn more here #DaretoBeam #BeamTeam
Tweet media one
2
5
87
@BeamTx
Beam Therapeutics
11 months
Today, we announced that in August, the first patient was treated with BEAM-201, a quadruplex-edited allogeneic CAR-T cell investigational therapy.
2
10
76
@BeamTx
Beam Therapeutics
3 years
Ahead of #JPM22 , we are excited to report progress across our ex vivo and in vivo base editing programs, as well as provide an update on anticipated 2022 milestones. We've also named our fourth development candidate, BEAM-301, for GSDIa. Read more:
Tweet media one
0
3
51
@BeamTx
Beam Therapeutics
3 years
We’re excited to see our manufacturing site in RTP, North Carolina coming to life! Building steel is going up quickly. We are building our new manufacturing facility to support our vision of providing life-long cures to patients #BeamTeam #DaretoBeam #workatBeam
Tweet media one
4
1
49
@BeamTx
Beam Therapeutics
2 years
Thank you for visiting us at Beam, Alexis Komor! Alexis' work, alongside Beam's @NicoleGaudelli , in Dr. David Liu's laboratory led to the original publication of the C-to-T base editor #DaretoBeam #BeamTeam
Tweet media one
3
4
44
@BeamTx
Beam Therapeutics
3 years
Today the #BeamTeam “raised the beam” (pun intended!) at our manufacturing facility in RTP, NC! This is an exciting moment & the next step in providing life-long cures to patients suffering from serious diseases. Thanks to our partners for being part of this journey! #DaretoBeam
3
4
41
@BeamTx
Beam Therapeutics
9 months
Today, Beam reported new preclinical data demonstrating the ability of its in vivo drug candidate, BEAM-301, to directly correct the R83C mutation, one of the primary disease-causing mutations of glycogen storage disease type Ia (GSDIa).
3
1
39
@BeamTx
Beam Therapeutics
11 months
Today, Beam reported new preclinical data demonstrating the ability of its in vivo drug candidate, BEAM-302, to directly correct the PiZ mutation, the primary disease-causing mutation associated with severe alpha-1 antitrypsin deficiency (AATD).
Tweet media one
2
3
35
@BeamTx
Beam Therapeutics
2 years
The Beam Story - The Inception of Base Editing - Chapter 1! We’re excited to share the 1st of 3 chapters over the next month! #BeamTeam #DaretoBeam
2
5
33
@BeamTx
Beam Therapeutics
2 years
Today, Beam announced the FDA has lifted the clinical hold and cleared the Investigational New Drug (IND) application for BEAM-201 for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL)/T cell lymphoblastic lymphoma (T-LL).
Tweet media one
1
5
34
@BeamTx
Beam Therapeutics
3 years
Today @BeamTx and @ApellisPharma announced an exclusive five-year research collaboration focused on the use of Beam’s proprietary base editing technology to discover new treatments for complement-driven diseases #DaretoBeam #BeamTeam
Tweet media one
1
6
32
@BeamTx
Beam Therapeutics
3 years
Holly Rees and the Lead Discovery group are seeking enthusiastic and innovative scientists with experience using automation to answer questions in molecular biology. Learn more about these opportunities here #DaretoBeam #BeamTeam #WorkatBeam
2
3
32
@BeamTx
Beam Therapeutics
4 years
We're the #BeamTeam . Breakthroughs in genetic medicines require a unique combination of cutting-edge exploratory science to enable new possibilities, & industrial rigor to convert them into therapeutic reality. When you #DaretoBeam , anything is possible! #BeamCulture #BeamCareers
2
4
29
@BeamTx
Beam Therapeutics
2 years
We announced new preclinical data demonstrating the potential of our multiplex base editing approach to both reduce viral markers – including hepatitis B surface antigen (HBsAg) expression – & prevent viral rebound of HBV in in vivo models
1
2
30
@BeamTx
Beam Therapeutics
2 years
Yesterday the #BeamTeam celebrated the ribbon cutting of our manufacturing facility in Durham, North Carolina! Thank you to all of our partners for making this day possible #DaretoBeam #BeamNC
Tweet media one
0
3
31
@BeamTx
Beam Therapeutics
9 months
Congrats @VerveTx for the first human data on an in vivo base editor!
1
2
28
@BeamTx
Beam Therapeutics
2 years
We’re excited to share that we have launched our new website! Check it out! Explore our science and learn more about the #BeamTeam #DaretoBeam
2
1
27
@BeamTx
Beam Therapeutics
3 years
We’re excited to share that for the third year in a row we have been named to @BostonGlobe 's #TopPlacestoWork list! Thank you to the entire #BeamTeam for your commitment to our patients and each other #DaretoBeam #workatbeam
0
1
25
@BeamTx
Beam Therapeutics
3 years
The #BeamTeam is proud to share that CFO TA Burrell was named to the @timmermanreport 's list, “On Juneteenth, Honoring 22 Black Biotech Leaders.” Thanks, TA, for making a significant impact on our vision of providing life-long cures to patients #DaretoBeam
Tweet media one
0
2
25
@BeamTx
Beam Therapeutics
4 years
Excellent job by the #BeamTeam ’s @NicoleGaudelli during today’s GenLive event: A CRISPR Approach to Genetic Medicine! Thank you to @GENbio for hosting the event #baseediting #geneediting #DaretoBeam
Tweet media one
0
4
23
@BeamTx
Beam Therapeutics
3 years
Are you interested in helping us develop and advance gene editing therapeutics? Michael Packer & the Liver Therapeutics group is hiring lab-based positions at all levels. Click here to learn more #BeamTeam #DaretoBeam #WorkatBeam #baseediting #liver #beam
Tweet media one
0
2
23
@BeamTx
Beam Therapeutics
3 years
Our In Vivo team is growing across all levels, and we are #hiring for motivated, passionate Scientists and RA’s to join the #BeamTeam ! If this sounds like you, connect with Nancy O’Sullivan to learn more #DaretoBeam #workatBeam
Tweet media one
0
1
19
@BeamTx
Beam Therapeutics
3 years
Today we welcome the @GuideTx team to the #BeamTeam ! Read the full press release below #DaretoBeam #BeamTeam #genetherapy #geneediting #workatBeam
Tweet media one
0
3
20
@BeamTx
Beam Therapeutics
4 years
We’re proud to share that our CEO @john_evans3 was named an @EY_US Entrepreneur Of The Year 2020 National Finalist! The #BeamTeam congratulates you, John! #EOYNE #innovation #geneediting #baseediting
Tweet media one
0
4
21
@BeamTx
Beam Therapeutics
3 years
Did you know the #BeamTeam utilizes innovative robotics to bring scientific discovery to patients faster? We’ve partnered w/ @formulatrix to be the 1st company to deploy rovers in our new automation lab! Interested in learning how we use lab automation? Connect w/ @gantzer16 !
0
1
19
@BeamTx
Beam Therapeutics
3 years
Congratulations to the #BeamTeam ’s @NicoleGaudelli on being named to @endpts 20 Under Forty in Biopharma list! Nicole, we are so proud of you and your team’s contributions #DaretoBeam #20under40
Tweet media one
0
2
19
@BeamTx
Beam Therapeutics
2 years
Today is an exciting day in the base editing space - great news from @VerveTx and we’re proud to have Beam mentioned alongside.
@statnews
STAT
2 years
The first patient ever has been dosed with a kind of gene-editing treatment known as a base editor, a newer way of utilizing CRISPR for gene editing.
0
16
46
0
1
18
@BeamTx
Beam Therapeutics
3 years
Today the #BeamTeam announced data from Beam’s novel LNP-mRNA formulation demonstrates in vivo editing in liver cells of non-human primates up to 52% and our first quarter 2021 financial results #DaretoBeam #ASGCT21
Tweet media one
0
1
18
@BeamTx
Beam Therapeutics
1 year
We are thrilled to announce that the #BeamTeam ’s Holly Rees was named to @Forbes 30 Under 30 Europe 2023: Science & Healthcare! Congratulations, Holly! Read Holly’s full #Forbes profile here: #DaretoBeam #30Under30 #WomenInScience
Tweet media one
0
0
20
@BeamTx
Beam Therapeutics
4 years
We are excited to announce the promotion of Courtney Wallace to Chief Business Officer of Beam. Congratulations, Courtney! The #BeamTeam is so proud of you!
Tweet media one
0
3
18
@BeamTx
Beam Therapeutics
10 months
We made the difficult decision to prioritize our portfolio and streamline our business operations, and with that comes saying goodbye to incredibly valued team members who have been instrumental to Beam’s success.
6
1
19
@BeamTx
Beam Therapeutics
2 years
The #BeamTeam ’s @john_evans3 will join the #STATBreakthrough Summit tomorrow at 10:25 ET for the session titled “CRISPR at a crossroads.” Learn more about the event here #DaretoBeam
Tweet media one
0
0
17
@BeamTx
Beam Therapeutics
1 year
We’re excited to share that Beam has been named to the Top Workplaces USA 2023 list! If you’re looking to join a company known for having a great culture & work environment, head over to our careers page and check out our open roles in both Cambridge & NC
0
3
18
@BeamTx
Beam Therapeutics
2 years
We’re excited to be named to the #bestplacestowork2022 list in the large company category! Thank you to the entire #BeamTeam for your commitment to each other and our patients. Interested in learning more about joining the Beam Team? Head over to our careers page! #DaretoBeam
@BosBizJournal
Boston Business Journal
2 years
Best Places to Work honorees announced — Large category
0
0
0
2
0
15
@BeamTx
Beam Therapeutics
3 years
Meet the #BeamTeam ’s @NicoleGaudelli at the @WSJ 's Future Of Everything Festival May 11-13! Nicole is #growing our Gene Editing Technologies Team and this is a great opportunity learn about the #BeamTeam #DaretoBeam #WSJFUTURE
Tweet media one
0
3
17
@BeamTx
Beam Therapeutics
3 years
Yesterday the #BeamTeam participated in the 8th annual Walk With the Stars hosted by the @SCDAAorg . Our team walked, ran and biked in support of one of their largest events dedicated to finding better treatments & a cure for #sicklecelldisease #MoveForSickleCell #SCD #DaretoBeam
Tweet media one
0
3
16
@BeamTx
Beam Therapeutics
2 years
Today Beam celebrates our 5-year anniversary! Thank you to all our Beam Team members for their commitment and hard work over the years. We strive to continue being a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong
1
1
16
@BeamTx
Beam Therapeutics
2 years
We recently celebrated the ribbon cutting of our new state-of-the-art manufacturing facility in NC! We're looking for Manufacturing & Quality professionals who are collaborative, passionate about helping patients, & excited to be part of building our facility #BeamNC #DaretoBeam
Tweet media one
1
1
15
@BeamTx
Beam Therapeutics
4 years
For the 2nd year in a row we've been named to @BostonGlobe 's Top Places to Work! The #BeamTeam ranked as the top-rated Biotech/Life Sciences company in the medium-size company category! #DaretoBeam #workatBeam #BeamCareers #workboston
0
2
16
@BeamTx
Beam Therapeutics
10 months
Yesterday, the #BeamTeam 's Amy Simon joined the #NORDSummit panel discussing: The New Frontier of Gene Editing: Can We Potentially Cure Genetic Diseases? Thanks for having us, @RareDiseases ! #DaretoBeam
Tweet media one
0
1
15
@BeamTx
Beam Therapeutics
3 years
The #BeamTeam announced preclinical data demonstrating the potential of Beam’s cytosine base editors to reduce viral markers, including hepatitis B surface antigen expression, and prevent viral rebound of hepatitis B virus in in vitro models: #DaretoBeam
Tweet media one
0
1
14
@BeamTx
Beam Therapeutics
3 years
The #BeamTeam is committed to each other, our patients & the community that we work, live & play in. Thank you to Chris Hill for sharing what the team has been up to & a huge thank you to @LS_Cares for partnering with us on so many great initiatives! #DaretoBeam #BeamCulture
2
0
13
@BeamTx
Beam Therapeutics
1 year
Today, Beam announced that Gopi Shanker, has been appointed as chief scientific officer. Dr. Shanker will report to @gciaramella1 , president of Beam, who has broad oversight of Beam’s research, manufacturing, regulatory, quality and pharmaceutical sciences organizations.
Tweet media one
1
1
15
@BeamTx
Beam Therapeutics
3 years
Congratulations to the #BeamTeam ’s @cory_sago for being named to @GeorgiaTech 's Forty Under Forty list! Learn more about Cory here #DaretoBeam #40under40
Tweet media one
1
1
14
@BeamTx
Beam Therapeutics
2 years
We are growing across multiple functions and are looking for fearless innovators to join us at our North Carolina manufacturing facility! Find your future with the #BeamTeam here #DaretoBeam
0
1
13
@BeamTx
Beam Therapeutics
9 months
Beam announced that @EliLillyandCo has agreed to acquire certain rights under Beam’s amended collaboration & license agreement with @VerveTx , including Beam’s opt-in rights to co-develop & co-commercialize Verve’s base editing programs for cardiovascular disease,
1
0
13
@BeamTx
Beam Therapeutics
3 years
Happy International Day of Women and Girls in Science! Today we celebrate the impact that women at Beam have had on our community of fearless innovators! #DaretoBeam #BeamTeam #WomenInScience #workatBeam #BeamCulture
0
2
14
@BeamTx
Beam Therapeutics
3 years
Thank you to the The Leukemia & Lymphoma Society for hosting the Light the Night walk in the Franklin Park Zoo. The #BeamTeam walked together to celebrate, honor and remember those touched by cancer #DaretoBeam #LightTheNight
Tweet media one
0
0
10
@BeamTx
Beam Therapeutics
4 years
We’re excited to announce the appointment of @KateWalshCEO , president and chief executive officer of the Boston Medical Center health system, to Beam’s board of directors. Welcome to the #BeamTeam , Kate! #DaretoBeam
Tweet media one
0
3
12
@BeamTx
Beam Therapeutics
2 years
Yesterday, @NicoleGaudelli presented at FASEB's Genome Engineering Conference on new research highlighting our internal efforts to develop improved conditioning regimens for patients with sickle cell disease (SCD) undergoing hematopoietic stem cell transplantation.
1
4
12
@BeamTx
Beam Therapeutics
1 year
Congratulations to the #BeamTeam ’s Holly Rees on being named to Business Insider's 30 Leaders Under 40 who are forging a new future for the healthcare industry in 2023! #DaretoBeam
4
3
13
@BeamTx
Beam Therapeutics
2 years
Beam and Orbital Therapeutics have entered into a license and research collaboration under which Orbital and Beam have each granted the other access to respective RNA technology and non-viral delivery technology. Learn more about the collaboration here:
Tweet media one
0
3
13
@BeamTx
Beam Therapeutics
3 years
Join Holly Rees and the Genome Editing Team as a scientist at Beam! #BeamTeam #workatBeam #DaretoBeam
0
0
13
@BeamTx
Beam Therapeutics
3 years
Thank you @FierceBiotech and @amirahalidrus for the great article on our collaboration with @ApellisPharma ! Check out the full article below #DaretoBeam #BeamTeam
Tweet media one
0
2
11
@BeamTx
Beam Therapeutics
2 years
Today the #BeamTeam celebrates International Women’s Day! We stand behind this year’s theme of #BreakTheBias as we work to forge women’s equality. Today, & every day, we honor the women at Beam for their achievements & for driving our mission forward #Internationalwomensday2022
Tweet media one
0
0
11
@BeamTx
Beam Therapeutics
2 years
The #BeamTeam will present new preclinical data from several programs across our base editing portfolio at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting. Read more on our updates here: #DaretoBeam
Tweet media one
0
0
10
@BeamTx
Beam Therapeutics
3 years
Happy National Intern Day! We had 13 interns and co-ops join the #BeamTeam this summer across many departments. Thank you to each of them for all of their hard work and contributions #DaretoBeam #workatBeam #NationalInternDay
Tweet media one
1
1
12
@BeamTx
Beam Therapeutics
2 years
Why do you support Rare Disease Day? #RareDiseaseDay #BeamTeam #DaretoBeam
Tweet media one
0
5
12
@BeamTx
Beam Therapeutics
11 months
We're proud to have been named a finalist at the BWB Awards in the Talent Acceleration category. A big thank you to the #BeamTeam for continuing to make Beam a great place to work & grow! Congrats to all the winners & finalists this year! #DaretoBeam #BeamTeam
Tweet media one
1
1
11
@BeamTx
Beam Therapeutics
11 months
Did you know that approximately 20 people will be diagnosed with a blood cancer every hour? That's a new diagnosis every three minutes... With this comes a new future. A new day-to-day. New uncertainty.
1
1
11
@BeamTx
Beam Therapeutics
3 years
November is Alpha-1 Awareness Month & throughout the month the Alpha-1 Foundation launches the #Alpha1Awareness campaign to increase awareness. The #BeamTeam is committed to raising awareness & encourages you to check out Alpha-1 Awareness resources here
Tweet media one
1
2
11
@BeamTx
Beam Therapeutics
3 years
Join Beam’s Liver Therapeutics Team! We’re #hiring for a scientist to help us to discover and develop liver therapies using state-of-the-art base editing technology #DaretoBeam #BeamTeam #workatBeam
Tweet media one
0
0
8
@BeamTx
Beam Therapeutics
2 years
Today, Beam reported progress across the company’s hematology, immunology-oncology and genetic disease portfolios and provided updates on anticipated upcoming milestones. Learn about these updates here: #BeamTeam #DaretoBeam
Tweet media one
0
2
10
@BeamTx
Beam Therapeutics
1 year
We are excited to share that Beam has been named to Forbes’ list of America’s Best Small Employers and only one of ten biotech companies recognized out of 300 companies across all industries! Congratulations, #BeamTeam ! #DaretoBeam
0
0
11
@BeamTx
Beam Therapeutics
3 years
Congratulations to the #BeamTeam ’s @NicoleGaudelli and @ianslaymaker on their recent review on Engineering Cas9 for human genome editing! Check out the full review here: #DaretoBeam
Tweet media one
0
1
10
@BeamTx
Beam Therapeutics
3 years
We’re hiring for several roles to support Beam’s manufacturing facility in RTP, North Carolina! Find your future with the #BeamTeam here #DaretoBeam
Tweet media one
0
2
8
@BeamTx
Beam Therapeutics
2 years
Congratulations to the Beam Immunology Team for their article on “Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL” released in @ASH_hematology . Read more below:
0
1
10
@BeamTx
Beam Therapeutics
3 years
Today the #BeamTeam celebrated #EarthDay by participating in the #charlesrivercleanup ! Thank you @charlesriver for hosting and organizing a great event #DaretoBeam #BeamCulture
Tweet media one
0
1
9
@BeamTx
Beam Therapeutics
2 years
This week is #GlycogenStorageDisease (GSD) week, a time for raising awareness of GSD and its impact on affected families. Today, we're sharing Alyssa's story and her life with GSD1a. #AGSD #GSDAwareness #GSDStrong #GSDBrave
0
1
10
@BeamTx
Beam Therapeutics
3 years
Our LNP Discovery team is growing! Connect with Cory Sago or visit our careers site to learn more about joining the #BeamTeam #DaretoBeam
0
2
9
@BeamTx
Beam Therapeutics
4 years
Great article from @barronsonline on the rare speed in which gene editing has emerged as biotech’s new cutting edge. We’re proud to have the #BeamTeam and our CEO @john_evans3 featured #geneediting #baseediting #innovation #JPM21 #JPM2021
Tweet media one
0
3
8
@BeamTx
Beam Therapeutics
2 years
We’re excited to be named a recipient of the @MALifeSciences Tax Incentive program. The program provides incentives to companies, of all sizes, looking to expand their efforts by creating new, long-term jobs in Massachusetts #DaretoBeam #BeamTeam
Tweet media one
0
1
10
@BeamTx
Beam Therapeutics
2 years
Did you know we partnered with @formulatrix to design and deploy the first ever lab rover platform? Check out how the #BeamTeam connects our high throughput integrated research platforms in our new Automation Lab! #DaretoBeam
0
2
8
@BeamTx
Beam Therapeutics
1 year
Today, Beam reported second quarter 2023 financial results and provided an update on clinical and pipeline progress. Read the full press release here: #DaretoBeam #BeamTeam
0
1
9
@BeamTx
Beam Therapeutics
2 years
Today, we’re sharing Jake's experience living with #GlycogenStorageDisease 1a (GSD1a). During this GSD week, we aim to heighten awareness of GSD by sharing stories of families living with GSD1a. #AGSD #GSDAwareness #GSDStrong #GSDBrave
0
0
9
@BeamTx
Beam Therapeutics
3 years
A big thank you to @LS_Cares for hosting the #BeamTeam and many other life science companies at the Mini Golf for Good Tournament! We had the BEST time! #DaretoBeam #BeamCulture
Tweet media one
0
0
9
@BeamTx
Beam Therapeutics
3 years
We're looking for a Scientist & a Senior Research Associate who are enthusiastic & creative thinkers to join Cindy Windohl & David Born on the Ophthalmology team! #DaretoBeam #BeamTeam #workatBeam
Tweet media one
1
1
9
@BeamTx
Beam Therapeutics
2 years
We're excited to share that Beam has been selected as a finalist for the 2022 Scrip Awards in the Business Development Team of the Year category! @Pharma_Scrip #ScripAwards #DaretoBeam #BeamTeam
Tweet media one
0
0
8
@BeamTx
Beam Therapeutics
10 months
The #BeamTeam 's Manmohan Singh participated in today's panel: Achieving Targeted Delivery of Gene Editing Therapies at the annual PODD: Partnerships in Drug Delivery conference! #DaretoBeam #PODD2023
Tweet media one
1
2
9
@BeamTx
Beam Therapeutics
4 years
When you Dare to Beam, anything is possible… #DaretoBeam #BeamTeam #BeamCulture #BeamCareers
0
1
8
@BeamTx
Beam Therapeutics
2 years
As part of our commitment to each other, Beam strives to support our team members and their families by offering comprehensive benefits, all of which are designed to help the #BeamTeam achieve well-being both at work and at home #Showusyourleave #DaretoBeam #workatBeam
0
0
9
@BeamTx
Beam Therapeutics
3 years
We are thrilled to welcome Amy Simon to the #BeamTeam as our Chief Medical Officer! Learn more about Amy and her background here: #DaretoBeam #BeamCulture
Tweet media one
0
1
9
@BeamTx
Beam Therapeutics
11 months
BEAM-201 is being evaluated in a Phase 1/2 clinical study for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia/T-cell lymphoblastic lymphoma (T-ALL/T-LL), a severe disease affecting children and adults.
1
1
8
@BeamTx
Beam Therapeutics
3 years
The #BeamTeam ’s @john_evans3 will participate in a fireside chat during the 2021 Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 9:30 a.m. ET. More on how you can watch the webcast here #DaretoBeam
Tweet media one
0
2
9
@BeamTx
Beam Therapeutics
9 months
We’re excited to be named to @biospace 's 2024 Best Places to Work list! Check out the full list here #DaretoBeam #BeamTeam
1
0
9
@BeamTx
Beam Therapeutics
2 years
We're excited to welcome Luis Brito to our LNP Platform team at Beam! Join Luis and the Formulation Science Team as an Associate Director/Director, Formulation Science!: #DaretoBeam #BeamTeam
Tweet media one
1
0
7
@BeamTx
Beam Therapeutics
3 years
The #BeamTeam is #growing ! Learn more about opportunities to join us here #DaretoBeam
Tweet media one
0
2
6
@BeamTx
Beam Therapeutics
2 years
The #BeamTeam is looking for a motivated and experienced Sr. Manager/Associate Director, Data Management to lead clinical data management activities in support of Beam’s clinical trials. To learn more, follow the link to our listing:
Tweet media one
0
1
7
@BeamTx
Beam Therapeutics
3 years
We’re expanding our geographical footprint to RTP, NC with the announcement of a 100,000 SF manufacturing facility! Join the #BeamTeam as Director of Manufacturing Sciences & Technology or Director of Project Management & Operational Readiness #DaretoBeam
Tweet media one
1
0
6
@BeamTx
Beam Therapeutics
4 years
The #BeamTeam today announced that the company will advance BEAM-201, a potent and specific anti-CD7, multiplex edited, allogeneic CAR-T therapy, as a development candidate for the treatment of T-cell acute lymphoblastic leukemia (T-ALL)
Tweet media one
0
2
8
@BeamTx
Beam Therapeutics
3 years
Shaunna joined the #BeamTeam because of the team’s commitment to each other #DaretoBeam #workatBeam #BeamCulture
0
1
7
@BeamTx
Beam Therapeutics
3 years
Thank you to @LaunchBio for having #BeamTeam member Brian Riley as part of today’s webinar: “Gene Therapy Thrives: Five Years of Growth in NC” #DaretoBeam
@TriangleRegion
Research Triangle Regional Partnership (RTRP)
3 years
From @BeamTx , @Sarepta , @NovartisGene , & @AstellasGeneTx on why NC is ideal for #genetherapy : ✅Access to talent & research at universities ✅Low cost of real estate ✅Availability, low cost, & stability of resources (construction, utilities, etc) ✅State & local incentives
Tweet media one
0
3
8
0
1
8
@BeamTx
Beam Therapeutics
2 years
We’re humbled to rank No. 4 on the @BostonGlobe ’s 2022 Top Places to Work in the “Large Companies” category, marking our fourth consecutive year as an honoree #DaretoBeam #BeamTeam
Tweet media one
0
1
8
@BeamTx
Beam Therapeutics
10 months
We’re excited to launch the new Fellowships page on our website! Our 2 year fellowship program is designed to help PhD, MD, & PharmD grads kickstart a career in the biotechnology industry. Learn more about the program and apply here #DaretoBeam #BeamTeam
1
0
7
@BeamTx
Beam Therapeutics
2 years
We are excited to present new preclinical findings at the @ASGCTherapy 25th Annual Meeting in Washington D.C this week. Beam research will be presented by Yvonne Aratyn-Schaus, Michael Packer, and Amy Yang. Learn more below! #BeamTeam #DaretoBeam #asgct22
0
0
8